These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36707834)

  • 1. Cognitive functioning in women with breast cancer: psychometric properties of the Arabic version of the Functional Assessment of Cancer Therapy-Cognitive Function Tool.
    Hassan M; Barakat Z; Fares Y; Abou-Abbas L
    Health Qual Life Outcomes; 2023 Jan; 21(1):9. PubMed ID: 36707834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer.
    Park JH; Bae SH; Jung YS; Jung YM
    Support Care Cancer; 2015 Sep; 23(9):2695-703. PubMed ID: 25666997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese population.
    Oliveira AF; Santos IM; Fernandes S; Bem-Haja P; Torres A
    BMC Psychol; 2022 Dec; 10(1):305. PubMed ID: 36517827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer.
    Cheung YT; Lim SR; Shwe M; Tan YP; Chan A
    Value Health; 2013; 16(6):1001-13. PubMed ID: 24041350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric performance of the Arabic versions of the Functional Assessment of Cancer Therapy-Breast plus Arm morbidity (FACT-B + 4) in patients with breast cancer related lymphedema: cross-sectional study.
    Al-Hoqail HA; Omar MTA; Al-Marwani MM; Al-Eisa ES
    BMC Womens Health; 2022 Jun; 22(1):207. PubMed ID: 35658863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon.
    Huijer HA; Sagherian K; Tamim H
    Qual Life Res; 2013 Aug; 22(6):1473-81. PubMed ID: 22961075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the validity and reliability of the Turkish version of the Functional Assessment of Cancer Therapy-Cognitive Function in cancer patients.
    Atasavun Uysal S; Yildiz Kabak V; Karakas Y; Karabulut E; Erdan Kocamaz D; Keser İ; Özdemir K; Düger T
    Palliat Support Care; 2022 Oct; 20(5):694-700. PubMed ID: 34470680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Japanese Version of the Functional Assessment of Cancer Therapy-Cognitive Function Version 3.
    Miyashita M; Tsukamoto N; Hashimoto M; Kajiwara K; Kako J; Okamura H
    J Pain Symptom Manage; 2020 Jan; 59(1):139-146.e3. PubMed ID: 31654740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric Performance of the Arabic Versions of the Cancer Behavior Inventory-Brief and the Functional Assessment of Cancer Therapy-Breast.
    Algamdi MM; Hanneman SK
    Cancer Nurs; 2019; 42(2):129-138. PubMed ID: 29461284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.
    Joly F; Lange M; Rigal O; Correia H; Giffard B; Beaumont JL; Clisant S; Wagner L
    Support Care Cancer; 2012 Dec; 20(12):3297-305. PubMed ID: 22549504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating the PROMIS cognitive function short form in cancer survivors.
    Henneghan AM; Van Dyk K; Zhou X; Moore RC; Root JC; Ahles TA; Nakamura ZM; Mandeblatt J; Ganz PA
    Breast Cancer Res Treat; 2023 Aug; 201(1):139-145. PubMed ID: 37330430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 Breast Cancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patients.
    El Fakir S; Abda N; Bendahhou K; Zidouh A; Bennani M; Errihani H; Benider A; Bekkali R; Nejjari C
    BMC Res Notes; 2014 Jan; 7():53. PubMed ID: 24447401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar.
    Bener A; Alsulaiman R; Doodson L; El Ayoubi HR
    J Family Med Prim Care; 2017; 6(4):824-831. PubMed ID: 29564271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Properties of the Arabic Version of the Functional Assessment of Chronic Illnesses Therapy-Fatigue in Arabic Cancer Patients.
    Al Maqbali M; Hughes C; Gracey J; Rankin J; Hacker E; Dunwoody L
    J Pain Symptom Manage; 2020 Jan; 59(1):130-138.e2. PubMed ID: 31647976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric evaluation of the Arabic version of the 5-item Problem Areas in Diabetes (AR-PAID-5) scale.
    Sayed Ahmed HA; Mohamed SF; Mostafa M; Elotla SF; Shah A; Shah J; Fouad AM
    BMC Prim Care; 2022 Jun; 23(1):148. PubMed ID: 35681150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.
    Cheung YT; Foo YL; Shwe M; Tan YP; Fan G; Yong WS; Madhukumar P; Ooi WS; Chay WY; Dent RA; Ang SF; Lo SK; Yap YS; Ng R; Chan A
    J Clin Epidemiol; 2014 Jul; 67(7):811-20. PubMed ID: 24656406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.